LLMpediaThe first transparent, open encyclopedia generated by LLMs

Proenkephalin

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: enkephalin Hop 4
Expansion Funnel Raw 43 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted43
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Proenkephalin
NameProenkephalin
HGNCid8831
EntrezGene5179
OMIM131330
RefSeqNM_001135690
UniProtP01210
Band23.3

Proenkephalin. It is the inactive precursor protein that is enzymatically cleaved to produce several important endogenous opioid peptides, including Met-enkephalin and Leu-enkephalin. The gene encoding this precursor is located on chromosome 8 in humans and is expressed in a wide range of tissues, most notably within the central nervous system and adrenal medulla. These enkephalin peptides function as crucial neurotransmitters and neuromodulators, playing key roles in pain perception, reward pathways, and stress response by acting primarily on delta opioid receptor and mu opioid receptor.

Structure and gene

The human gene for proenkephalin, designated as PENK, is situated on the long arm of chromosome 8 at locus 8q23.3. This gene is organized into four exons and three introns, and its transcription gives rise to a messenger RNA that is translated into a 267-amino acid polypeptide. The structure of the precursor protein contains multiple copies of enkephalin sequences, including four copies of Met-enkephalin, one copy of Leu-enkephalin, and one copy of the extended peptide Met-enkephalin-Arg-Phe. These active peptide sequences are flanked by pairs of basic amino acid residues, such as lysine and arginine, which serve as recognition sites for proteolytic processing enzymes. Research into the gene's regulation has been advanced by studies at institutions like the National Institutes of Health and the Max Planck Society.

Biosynthesis and processing

Biosynthesis begins with the transcription of the PENK gene in the cell nucleus, followed by translation on ribosomes associated with the endoplasmic reticulum. The initial product, preproenkephalin, contains a signal peptide that directs it into the secretory pathway. Within the trans-Golgi network and subsequently in secretory vesicles, the proprotein is cleaved by a series of specific enzymes. These processing enzymes include members of the prohormone convertase family, such as PC1/3 and PC2, as well as carboxypeptidase E. This proteolytic cascade liberates the active enkephalin peptides, which are then stored in dense-core vesicles. These vesicles undergo calcium-dependent exocytosis in response to neuronal depolarization, releasing the peptides into the synaptic cleft.

Function and clinical significance

The primary functional role of proenkephalin-derived peptides is to modulate synaptic transmission by activating G protein-coupled receptors, specifically the delta opioid receptor and mu opioid receptor. This activation inhibits the release of excitatory neurotransmitters like glutamate and substance P, thereby producing analgesic effects. Beyond pain modulation, enkephalins are involved in regulating mood, reward, and responses to stress within brain regions like the periaqueductal gray, striatum, and limbic system. Clinically, circulating levels of the stable proenkephalin fragment, penkid, have emerged as a novel biomarker in emergency medicine, particularly for assessing acute kidney injury and heart failure in patients presenting to the emergency department. Its measurement is often compared to established markers like N-terminal prohormone of brain natriuretic peptide.

Research and therapeutic potential

Ongoing research explores the therapeutic potential of targeting the proenkephalin system. Strategies include developing enzyme inhibitors to enhance endogenous enkephalin levels, such as enkephalinase inhibitors, and designing synthetic peptides that mimic enkephalin action. Investigations led by organizations like the National Institute on Drug Abuse focus on its role in addiction and reward, given the interplay between endogenous opioids and drugs like morphine. Furthermore, gene therapy approaches, involving the delivery of the PENK gene via viral vectors like adeno-associated virus, are being studied in animal models for chronic pain conditions. The potential of proenkephalin-derived biomarkers in critical care is also a major focus for consortia like the European Society of Intensive Care Medicine.

Category:Peptides Category:Neurochemistry Category:Opioid peptides